Intermittent fasting and plant-based eating during chemotherapy
Part of Cancer clinical trials.
This pilot study tests whether alternating periods of lower calorie intake, along with a plant-based diet, is safe and feasible for people receiving chemotherapy. If it helps, it could support better comfort and treatment tolerance during cancer therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and have confirmed cancer that will be treated with chemotherapy
- You expect to live at least 6 months
- Your recent blood tests show your counts and organs are strong enough for chemotherapy (white blood cells, neutrophils, platelets, hemoglobin)
- Your kidney and liver blood tests are within allowed ranges (creatinine and bilirubin, AST/ALT)
- You can do usual daily activities fairly well (ECOG 0–1); ECOG 2 or higher is not allowed
- No serious infection or fever in the week before starting, and you can follow the diet/plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether eating low-protein meals helps people with metastatic cancer feel better or tolerate immunotherapy (immune checkpoint inhibitors). It’s mainly a pilot/feasibility study, meaning the goal is to see if the diet is safe and doable during treatment.
This trial tests whether intermittent fasting (alternating between eating and not eating for certain periods) can help men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). It aims to see if fasting during treatment can reduce side effects or improve how well the therapy works.
This study tests whether intermittent fasting is safe and doable for people with lymphoma who are getting standard chemotherapy (R-CHOP or ABVD). It aims to see if adding fasting periods can help reduce side effects.
This study tests whether periods of fasting (eating very little for set times) combined with immunotherapy drugs might help treat advanced cancers like lung, stomach, liver, or melanoma. The goal is to see if fasting helps the immune-boosting drugs work better.
This trial tests whether alternating between a fasting day and a normal eating day can help people recovering from gynecologic cancer surgery while they receive chemotherapy. It aims to see if this eating pattern is safe and helpful during treatment.
This trial studies whether a carefully planned “fasting-mimicking” diet can be safely added to chemotherapy for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. It may help improve how the body handles treatment, but you must meet specific nutrition and cancer-response criteria.
Hear when a new Medical Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.